1955 Capital

Business Insider: 40 and Under Silicon Valley Biotech Stars: Ben Tseng

Business Insider: 40 and Under Silicon Valley Biotech Stars: Ben Tseng

Putting millions of dollars into bold new technologies can be a delicate business when lives hang in the balance. But every day some of the sharpest minds in Silicon Valley make big bets on tools and techniques that promise to cure disease, help fix the food system, and even prolong life…. These are the most interesting and ambitious biotech investors, age 40 and under, on the West Coast.

Benjamin Tseng is a principal at venture-capital firm 1955 Capital, where he focuses on advanced technologies in energy, healthcare, food, agriculture, and new manufacturing models…. Tseng is interested in the potential for emerging technologies to help feed the planet and spot disease early. He's also focused on healthcare and renewable energy. His firm has a particular emphasis on connecting startups in North America and Europe with market opportunities in China, which has some of the largest global demand for new products focused on health and clean tech.

AgFunderNews: 6 Questions with Ex-Khosla Partner Andrew Chung on his New $200m VC Fund

AgFunderNews: 6 Questions with Ex-Khosla Partner Andrew Chung on his New $200m VC Fund

A former partner of the venture capital giant Khosla Ventures, Andrew Chung, today launched his own venture firm, 1955 Capital. The fund, which has raised $200 million at first close, will invest in startups in the energy, food and agriculture, education and health sectors.

Forbes: With $200 Million, New Venture Firm 1955 Capital Plans To Bring Western Tech To China - Forbes

Forbes: With $200 Million, New Venture Firm 1955 Capital Plans To Bring Western Tech To China - Forbes

Andrew Chung hasn’t had the easiest job in venture capital. For the past ten years, the investor has maintained his focus mostly on cleantech startups when the majority of his VC peers have long since abandoned that market for companies that don’t burn through so much cash. He began first at Lightspeed Venture Partners and most recently at Khosla Ventures.

Newly Formed 1955 Capital Launches With First Close of $200 Million

Los Altos, CA, Feb. 24, 2016 – 1955 Capital announced the launch of its venture capital firm with an initial close on $200 million in anchor commitments, exceeding its initial target and making it one of the largest first­-time independent venture firm launches in recent years. The firm will invest in technologies developed in the Americas and Europe that can help solve the developing world's greatest challenges in areas like energy, food, agriculture, health, education and sustainable manufacturing. 1955 Capital is founded and managed by Andrew Chung, a former partner at Khosla Ventures, with extensive experience and success investing in these sectors and commercializing numerous technologies in China and other regions.

It’s Time for Something New

Last year, I went to a dinner where Madeleine Albright was the guest of honor, and she said some things that really resonated with me: The U.S. and China are more codependent on each other than any two countries have ever been in history. There’s no escaping the fact that we need each other. More importantly, we need to find the right way to work together.

That’s why the launch of 1955 Capital is so important to me. It’s a new venture firm I founded focused on funding technologies in developed countries that can be rapidly commercialized and scaled to solve pressing challenges in the developing world — starting with China.

We’re talking about taking on big, bold challenges like air pollution, renewable energy, food security and safety, health care delivery, accessible education, and sustainable manufacturing. I’ve watched as fewer and fewer firms pursue these sectors in recent years due to risk and fear of failure.